Shares of Cardiol Therapeutics Inc. (OTCMKTS:CRTPF – Get Free Report) traded up 1.6% during mid-day trading on Wednesday. The stock traded as high as $1.9550 and last traded at $1.89. 722,278 shares traded hands during mid-day trading, an increase of 976% from the average daily volume of 67,097 shares. The stock had previously closed at $1.86.
Cardiol Therapeutics Stock Performance
The company has a 50 day simple moving average of $1.68 and a 200 day simple moving average of $1.37.
Cardiol Therapeutics Company Profile
Cardiol Therapeutics Inc is a Canadian clinical-stage biotechnology company focused on developing therapies for inflammatory diseases of the heart. The company’s research is centered on conditions such as acute myocarditis and recurrent pericarditis, for which treatment options remain limited.
Its lead investigational product, CardiolRx, is an oral pharmaceutical formulation of cannabidiol that does not contain the intoxicating component of cannabis, tetrahydrocannabinol (THC). CardiolRx is being evaluated in clinical studies for its potential to reduce inflammation and other disease-related effects in patients with myocarditis and pericarditis.
Featured Stories
- Five stocks we like better than Cardiol Therapeutics
- Costco Ends Its Fiscal Year on a High Note, Eyes Big Expansion
- Cracker Barrel Stock Is Rallying Again, But the Turnaround Still Has a Traffic Problem
- Oracle’s Force Majeure Notice Exposes a Bigger Problem for the AI Build-Out
- Oil May Be Stronger Than It Looks—And Diamondback Is on Sale
Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
